27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...
23 February 2024 - A West Coast dad is receiving “outdated treatment” for his leukaemia because PHARMAC’s policies are blocking ...
23 February 2024 - Late last year, many of my colleagues returned from the largest international gathering of doctors who ...
14 February 2024 - PHARMAC is funding two new cancer treatments, for advanced breast cancer, and for blood cancer, which will ...
11 February 2024 - Multiple myeloma, a common blood cancer, is incurable, but can be survived for years with the right ...
21 December 2023 - An Auckland man has resorted to treatment for an aggressive bone marrow cancer in Germany after ...
12 December 2023 - PHARMAC is seeking feedback on a proposal to fund two new treatments for advanced breast cancer and ...
1 December 2023 - The December 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is ...
5 September 2023 - Drug buying agency PHARMAC is not moving fast enough, says a gut cancer patient paying more ...
27 August 2023 - Myeloma New Zealand is welcoming Pharmac's announcement of more blood cancer medicines, but says the country is ...
24 August 2023 - PHARMAC is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the ...
22 August 2023 - It's being suggested National's cancer drug funding promise has put PHARMAC in a difficult position. ...
21 August 2023 - The National Party wants to bring back the $5 prescription fee for those who can afford ...
11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type ...